0480 Effects of a Novel Oral Orthotic on Palatoglossal Muscle Tone as a Method for Maintaining Upper Airway Patency

Abstract Introduction The palatoglossal muscle, which is the only tongue muscle innervated by the vagus nerve, maintains oropharyngeal airway patency. Mandibular advancement devices demonstrate increased airway caliber through anterior tongue repositioning, yet the impact of occlusal modification on palatoglossal tone has not been well characterized. An increase in its resting tone may reduce airway collapsibility and potentially provide a non-invasive mechanism of vagal stimulation. This study evaluated whether a novel unilateral bite-block oral orthotic (UBB) increases resting palatoglossal muscle tone by altering vertical dimension and occlusal contact, by affecting neuromuscular feedback and palatoglossal electromyography (EMG) activity. Methods Nineteen healthy adults underwent intraoral surface EMG (sEMG) using the BioEMG III system and a custom 3-D printed palatoglossal surface electrode contoured to the palatoglossal fold and secured intraorally with cyanoacrylate adhesive. For each participant, the UBB was inserted on a side opposite to the electrode lead to avoid wire interference. Each participant completed five baseline pre-UBB and five post-UBB recordings during relaxed nasal breathing in the supine position. EMG amplitudes were compared with nonparametric Wilcoxon Signed-Rank and Sign Tests in Python and SPSS. Results Mean resting EMG amplitude increased from 20.77±20.280 μV (pre-UBB) to 34.70±32.859 μV post-UBB (90.5% increase), with 16 of 19 participants showed higher post-UBB activity. Both the Wilcoxon signed-rank test (Z=-3.30, p<.001, large effect size r=.76) and two-tailed Sign Test (p=.004) showed significant increased resting EMG amplitude from pre-UBB to post-UBB conditions. Conclusion The UBB significantly increased palatoglossal resting tone. This increase suggests a neuromuscular facilitation effect, potentially mediated by an increase in oral cavity dimensions that direct the tongue superiorly and anteriorly. This would require the palatoglossal muscle to lift and elevate the posterior portion of the tongue. The UBB does not block anterior tongue movement nor prevent a more superior position, and the genioglossus muscle can reposition the tongue anteriorly concurrent to the elevated posterior portion controlled by palatoglossal muscles. This lessens the airway blocking potential of the tongue and may reduce sleep-disordered breathing. These findings support further UBB evaluation as a non-invasive vagus-nerve stimulator capable of enhancing upper-airway muscle stability during sleep and potentially treating sleep-related breathing disorders. Support (if any) Vivos Therapeutics, Inc.

Authors

Institutions

Publication Details

Journal
SLEEP
Published
2026-05-01
DOI
https://doi.org/10.1093/sleep/zsag091.0479
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

0480 Effects of a Novel Oral Orthotic on Palatoglossal Muscle Tone as a Method for Maintaining Upper Airway Patency

Scott Simonetti, Colette Cozean, Clete Kushida, Greg Kamyszek
SLEEP
Obstructive Sleep Apnea Research
article

0480 Effects of a Novel Oral Orthotic on Palatoglossal Muscle Tone as a Method for Maintaining Upper Airway Patency

Scott Simonetti, Colette Cozean, Clete Kushida, Greg Kamyszek
article en

Abstract

Abstract Introduction The palatoglossal muscle, which is the only tongue muscle innervated by the vagus nerve, maintains oropharyngeal airway patency. Mandibular advancement devices demonstrate increased airway caliber through anterior tongue repositioning, yet the impact of occlusal modification on palatoglossal tone has not been well characterized. An increase in its resting tone may reduce airway collapsibility and potentially provide a non-invasive mechanism of vagal stimulation. This study evaluated whether a novel unilateral bite-block oral orthotic (UBB) increases resting palatoglossal muscle tone by altering vertical dimension and occlusal contact, by affecting neuromuscular feedback and palatoglossal electromyography (EMG) activity. Methods Nineteen healthy adults underwent intraoral surface EMG (sEMG) using the BioEMG III system and a custom 3-D printed palatoglossal surface electrode contoured to the palatoglossal fold and secured intraorally with cyanoacrylate adhesive. For each participant, the UBB was inserted on a side opposite to the electrode lead to avoid wire interference. Each participant completed five baseline pre-UBB and five post-UBB recordings during relaxed nasal breathing in the supine position. EMG amplitudes were compared with nonparametric Wilcoxon Signed-Rank and Sign Tests in Python and SPSS. Results Mean resting EMG amplitude increased from 20.77±20.280 μV (pre-UBB) to 34.70±32.859 μV post-UBB (90.5% increase), with 16 of 19 participants showed higher post-UBB activity. Both the Wilcoxon signed-rank test (Z=-3.30, p<.001, large effect size r=.76) and two-tailed Sign Test (p=.004) showed significant increased resting EMG amplitude from pre-UBB to post-UBB conditions. Conclusion The UBB significantly increased palatoglossal resting tone. This increase suggests a neuromuscular facilitation effect, potentially mediated by an increase in oral cavity dimensions that direct the tongue superiorly and anteriorly. This would require the palatoglossal muscle to lift and elevate the posterior portion of the tongue. The UBB does not block anterior tongue movement nor prevent a more superior position, and the genioglossus muscle can reposition the tongue anteriorly concurrent to the elevated posterior portion controlled by palatoglossal muscles. This lessens the airway blocking potential of the tongue and may reduce sleep-disordered breathing. These findings support further UBB evaluation as a non-invasive vagus-nerve stimulator capable of enhancing upper-airway muscle stability during sleep and potentially treating sleep-related breathing disorders. Support (if any) Vivos Therapeutics, Inc.

SLEEPVol. 49(Supplement_1)
Vividion Therapeutics (United States) (US), Eye Center (SA), CS Diagnostics (DE), Stanford University (US)
Openalex Percentile: Top 8%
Obstructive Sleep Apnea Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.